AbbVie holds the highs after a powerful opening run

AbbVie is at week 4 of a buy signal, +16% since entry: 2 of the 3 statistical targets of our most advanced model have already been hit and frozen, with the third still open in the 257 area. Health Care has surged — XLV up 7% in the past week — and the IQS at 78 in tension confirms a mature, advanced structure. The first active management window is 2 weeks away.